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Introduction: Dukes A stages of colorectal cancer are rarely reported to metastasize. Subcutaneous or skin
metastases from colon cancer are rare events and usually indicate widespread disease.
Case presentation: We present the case of a 72-year-old Caucasian woman with Dukes A colorectal cancer at
diagnosis and, three years later, a single secondary subcutaneous involvement with no other metastatic sites. The
description of this case is supported by critical analysis of its clinical, radiological and pathological features. Our
report illustrates that diagnosis can be difficult and controversial when relapse occurs in early stage patients and at
uncommon sites.
Conclusion: The unusual and aggressive course of the reported disease stresses the importance of intensive follow-up in
colorectal cancer patients with good prognostic factors.
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Colorectal carcinoma most often metastasizes to liver
and lung, while subcutaneous or skin metastases are rare
[1,2], accounting for only 5% of such cases [3]. The most
common malignancies reported to metastasize to the
skin, both in men and women, are lung and breast can-
cers [4].
Usually, for almost all cancers, skin involvement is syn-
onymous with extensive disease and frequently implies a
poor prognosis [5,6]. In colorectal cancer, this event occurs
mostly on the incision scars, but is also seen on the skin of
the extremities, head and neck, and penis [7-9]. Some
authors, such as Kaufmann et al., have suggested two
hypotheses for this metastatic involvement: the first one
implies a lymphatic and hematogenous spread of disease,
while the second one speculates on an implantation during
surgery [10].
Ulceration, nodules, bullae or fibrotic processes are
the most common signs of cutaneous metastases.* Correspondence: gianpaolo.spinelli@uniroma1.it
1Department of Medical-Surgical Science and Biothecnology, Oncology Unit,
S.Maria Goretti Hospital, Latina - University of Rome “Sapienza” Corso della
Repubblica, 04100, Latina, Italy
Full list of author information is available at the end of the article
© Lo-Russo et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orIn stage Dukes A, colorectal cancer involves only the
innermost lining of the colon or rectum, with minimal
invasiveness in the muscular layer.
In patients with this stage of cancer, relapse is very
rare [11]. Here we describe the case of a 72-year-old
woman with Dukes A colorectal cancer at diagnosis, and
three years later, a single secondary involvement of the
subcutaneous tissue of the left paravertebral dorsal
region.
Case presentation
A 72-year-old Caucasian woman underwent a right
hemicolectomy for a Dukes A colon cancer in August 2008
(staging: pT2, pN0-0/27nodes, G2). Computed tomography
(CT) of her abdomen, pelvis, and chest did not show any
distant metastases, so she was not treated further. Follow-
up examinations were negative until August 2009 when
mammography showed a suspicious lesion of the left
breast. In September 2009 a left superior and external
quadrantectomy was performed. Histological examination
revealed breast intraductal carcinoma (staging: pTis, p N0).
For this new pathology, the patient was only treated with
radiotherapy. She continued her follow-up examinations
for colorectal cancer. She remained asymptomatic until
May 2011, with no clinical or radiological signs of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Hematoxylin/Eosin (40×): Abortive glands and atypical mitosis (arrow).
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swelling, affecting the skin of the left paravertebral dorsal
region. Serum tumor markers were not increased and
colonoscopy did not show any local disease relapse. A chest
X-ray excluded pulmonary metastasis and an abdominal
ultrasound did not detect either liver metastases orFigure 2 Immunostaining with keratin 20 (20×): the positivity is markperitoneal dissemination. Therefore, an ultrasound scan of
the dorsal tumefaction was performed, showing a suspected
heterogeneous, solid and vascularized lesion. She under-
went a radical en-bloc resection of the dorsal swelling.
Histological analysis of the excised specimen revealed a
metastatic poorly differentiated adenocarcinoma, mosted but not diffused.
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skin and the subcutaneous tissue.
Macroscopically, the surgical specimen consisted of
a radical en-bloc resection of subcutaneous tissue (soft-
tissue) of 4x2.5x2cm which contained a nodular lesion
of 3.2cm diameter. The cut surface was white to yellow-
ish white and showed areas of necrosis and hemorrhage.
The excised specimen was fixed in 10% buffered forma-
lin and embedded in paraffin. Sections of 4μm were pre-
pared and routinely stained with hematoxylin and eosin.
Further sections were examined immunohistochemically
using a streptavidin-biotin complex technique (DAKO).
Prediluted antibodies against the following antigens were
used: keratin 20 protein (monoclonal, 1:50; ZymedW),
keratin 7 (monoclonal, 1:50; ZymedW), Thyroid tran-
scription factor 1 (TTF-1) (monoclonal, 1:100; ZymedW),
anti-estrogen receptor (monoclonal, 1:50; DAKO), and
anti-progesterone receptor (monoclonal, 1:50; DAKO).
Microscopically, the tumor was characterized by nests
and islands of epithelial cells with only scattered abortive
glands. The cells had atypical nuclei, with evidence
of nucleoli, abundant eosinophilic cytoplasm without
sharply defined outlines. The inflammatory infiltrate was
marked and there were hemorrhagic foci and areas of
necrosis. The mitosis was either frequently or sometimes
infrequently atypical (Figure 1). The cells were focally
positive for keratin 20 (Figure 2). Keratin 7, TTF1, estro-
gen and progesterone receptors were negative. The mor-
phologic aspects and the immunohistochemical results
were considered specific for a colonic origin. In this set-
ting, the neoplasia was also evaluated for K-ras mutation
and the molecular analysis showed the absence of muta-
tion on codon 12 and 13 (wild type). The total body CT
revealed no evidence of visceral distant metastases but
showed suspicious abdominal colliquative lymphadenop-
athy. The patient is being treated with FOLFIRI ( leucov-
orin (folinic acid), fluorouracil, irinotecan hydrochloride) +
bevacizumab and she remains asymptomatic.
Discussion
Colorectal cancer is one of the most frequent oncological
diseases. This clinical history shows a rare pattern of colon
cancer metastasis. In patients with Dukes A, colon carcin-
oma relapse is rare [11]. Cutaneous or subcutaneous metas-
tases are uncommon in colorectal cancer [1,2], as well as in
carcinomas that have originated elsewhere [5,6,12,13].
The identification of this type of metastasis in many
types of cancer is indicative of a poor prognosis with the
presence of disseminated disease [5,6]. The study by
Schoenlaub et al. reviewed 200 cases of cancers with
cutaneous or subcutaneous metastasis and reported that
among these, patients with colorectal cancer had a
median survival of 4.4 months [5]. On the other hand, a
retrospective study by Lookingbill et al. showed amedian survival of 18 months in patients with the same
characteristics [6].
A finding of isolated subcutaneous metastases of colo-
rectal cancer without other metastatic sites is extremely
rare and may delay the diagnosis by several months [14].
In our case, the rarity of this event caused many diffi-
culties in the correct diagnosis and in the right thera-
peutic approach.
From a biological perspective, this case outlines the
plural-phenotypic nature of cancer: the course of disease
that we report here is clearly determined by a peculiar
cancer cell population with specific biology and homing
features.
Conclusion
Despite the Dukes A staging, G2 grading and the ab-
sence of an increase in serum tumor markers, the char-
acteristics of this cancer phenotype appear to be rather
aggressive. Studies in molecular biology are strongly
warranted to distinguish patients with a peculiar clinical
course and prognosis. Intensive follow-up is also indi-
cated in patients with good prognostic factors at
diagnosis.
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